由于GLP一1半衰期短的生理特点， 限制了其在临床的应用，然而肠促胰岛素拟似物（incretin mimetic）正可弥补这一点。
基于8个网页-相关网页
·2,447,543篇论文数据，部分数据来源于NoteExpress
It is the first approval for an incretin mimetic drug, which stimulates insulin secretion.
FORBES: Magazine Article
It's known as an incretin mimetic and is a synthetic version of a compound found in the venom of a Gila monster, a lizard in the southwestern United States.
CNN: Diabetes drug Byetta tied to kidney problems, says FDA
应用推荐
模块上移
模块下移
不移动